Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo.

J Med Chem 2014 Jun 11;57(12):5333-47. Epub 2014 Jun 11.

Genextra Group, Congenia s.r.l. , Via Adamello 16, 20139 Milan, Italy.

In this account, we report the development of a series of substituted cinnamic anilides that represents a novel class of mitochondrial permeability transition pore (mPTP) inhibitors. Initial class expansion led to the establishment of the basic structural requirements for activity and to the identification of derivatives with inhibitory potency higher than that of the standard inhibitor cyclosporine-A (CsA). These compounds can inhibit mPTP opening in response to several stimuli including calcium overload, oxidative stress, and thiol cross-linkers. The activity of the cinnamic anilide mPTP inhibitors turned out to be additive with that of CsA, suggesting for these inhibitors a molecular target different from cyclophylin-D. In vitro and in vivo data are presented for (E)-3-(4-fluoro-3-hydroxy-phenyl)-N-naphthalen-1-yl-acrylamide 22, one of the most interesting compounds in this series, able to attenuate opening of the mPTP and limit reperfusion injury in a rabbit model of acute myocardial infarction.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm500547cDOI Listing
June 2014

Publication Analysis

Top Keywords

permeability transition
8
transition pore
8
mitochondrial permeability
8
mptp inhibitors
8
cinnamic anilides
8
requirements activity
4
turned additive
4
structural requirements
4
additive csa
4
inhibitors turned
4
basic structural
4
identification derivatives
4
anilide mptp
4
activity identification
4
cinnamic anilide
4
csa suggesting
4
molecular target
4
class expansion
4
target cyclophylin-d
4
expansion led
4

Altmetric Statistics

Similar Publications